Jul242024MHRA approves Comirnaty JN.1 COVID-19 vaccine for adults and children from infancy HM Government TwitterLinkedinFacebookemailThe Medicines and Healthcare products Regulatory Agency (MHRA) has today, 24 July, approved an adapted Pfizer/BioNTech COVID-19 vaccine (Comirnaty) that targets the JN.1 COVID-19 subvariant. Follow this news feed:
